Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

TELESTA THERAPEUTICS INC > New poster
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Frogger2on Sep 25, 2014 12:22pm
205 Views
Post# 22969950

RE:RE:RE:RE:New poster

RE:RE:RE:RE:New poster
 
  1.  Also add clincal data publication in a high impact urology journal to expand KOL network and clinical support for MCNA approval as a near term catalyst.
 
  1. This along with Orphan drug status approval are near term and I believe will get us to a buck buy the new year.

Our previous management were not able to provide and publish legitimate clinical support data other than describing it as the golden goose.
  1.  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities